Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

752 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Focal therapy for primary tumor and metastases in de novo or recurrent oligometastatic prostate cancer: current standing and future perspectives.
Tsaur I, Blaheta RA, Dotzauer R, Brandt MP, Gandaglia G, Sinescu I, Mirvald C, Olivier J, Surcel C; EAU-YAU Prostate Cancer Working Party. Tsaur I, et al. Among authors: olivier j. World J Urol. 2023 Aug;41(8):2077-2090. doi: 10.1007/s00345-022-04162-5. Epub 2022 Oct 2. World J Urol. 2023. PMID: 36183289 Review.
Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study.
Clery R, Grande P, Seisen T, Gobert A, Duquesne I, Villers A, Olivier J, Bernhard JC, Robert G, Beauval JB, Prudhomme T, Bruyère F, Lainé-Caroff P, Waltregny D, Guillonneau B, Panarello D, Ruffion A, De Bayser H, de La Taille A, Roupret M. Clery R, et al. Among authors: olivier j. World J Urol. 2019 Aug;37(8):1491-1498. doi: 10.1007/s00345-019-02683-0. Epub 2019 Feb 21. World J Urol. 2019. PMID: 30790014
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidence.
Laine C, Gandaglia G, Valerio M, Heidegger I, Tsaur I, Olivier J, Ceci F, van den Bergh RCN, Kretschmer A, Thibault C, Chiu PK, Tilki D, Kasivisvanathan V, Preisser F, Zattoni F, Fankhauser C, Kesch C, Puche-Sanz I, Moschini M, Pradere B, Ploussard G, Marra G; EAU-YAU Prostate Cancer Working Party. Laine C, et al. Among authors: olivier j. Curr Opin Urol. 2022 Jan 1;32(1):69-84. doi: 10.1097/MOU.0000000000000946. Curr Opin Urol. 2022. PMID: 34812201 Free article.
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future Perspectives.
Kretschmer A, van den Bergh RCN, Martini A, Marra G, Valerio M, Tsaur I, Heidegger I, Kasivisvanathan V, Kesch C, Preisser F, Fankhauser CD, Zattoni F, Ceci F, Olivier J, Chiu P, Puche-Sanz I, Thibault C, Gandaglia G, Tilki D, On Behalf Of The Yau Prostate Cancer Working Group. Kretschmer A, et al. Among authors: olivier j. Cancers (Basel). 2021 Dec 29;14(1):147. doi: 10.3390/cancers14010147. Cancers (Basel). 2021. PMID: 35008310 Free PMC article. Review.
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review.
Heidegger I, Kesch C, Kretschmer A, Tsaur I, Ceci F, Valerio M, Tilki D, Marra G, Preisser F, Fankhauser CD, Zattoni F, Chiu P, Puche-Sanz I, Olivier J, van den Bergh RCN, Kasivisvanathan V, Pircher A, Virgolini I, Gandaglia G. Heidegger I, et al. Among authors: olivier j. Ther Adv Med Oncol. 2022 Mar 5;14:17588359221081922. doi: 10.1177/17588359221081922. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35273651 Free PMC article. Review.
The Detection of Prostate Cancer with Magnetic Resonance Imaging-Targeted Prostate Biopsies is Superior with the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-Institutional Study.
Zattoni F, Marra G, Kasivisvanathan V, Grummet J, Nandurkar R, Ploussard G, Olivier J, Chiu PK, Valerio M, Gontero P, Guo H, Zhuang J, Barletta F, Leni R, Frydenberg M, Moon D, Hanegbi U, Landaumailto A, Snow R, Apfelbeck M, Kretschmer A, van den Bergh R, Novara G, Briganti A, Dal Moro F, Gandaglia G. Zattoni F, et al. Among authors: olivier j. J Urol. 2022 Oct;208(4):830-837. doi: 10.1097/JU.0000000000002802. Epub 2022 Sep 9. J Urol. 2022. PMID: 36082555
Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens.
Martini A, Touzani A, Beauval JB, Ruffion A, Olivier J, Gasmi A, Dariane C, Thoulouzan M, Barret E, Brureau L, Créhange G, Fiard G, Gauthé M, Renard-Penna R, Roubaud G, Sargos P, Roumiguié M, Timsit MO, Mathieu R, Villers A, Rouprêt M, Fromont G, Ploussard G; CC-AFU, Cancerology Committee of the Association Française d’Urologie. Martini A, et al. Among authors: olivier j. World J Urol. 2022 Dec;40(12):2931-2937. doi: 10.1007/s00345-022-04202-0. Epub 2022 Nov 7. World J Urol. 2022. PMID: 36342512
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.
Zattoni F, Marra G, Martini A, Kasivisvanathan V, Grummet J, Harkin T, Ploussard G, Olivier J, Chiu PK, Valerio M, Marquis A, Gontero P, Guo H, Zhuang J, Frydenberg M, Moon D, Morlacco A, Kretschmer A, Barletta F, Heidegger I, Tilki D, van den Bergh R, Dal Moro F, Briganti A, Montorsi F, Novara G, Gandaglia G; EAU-YAU Prostate Cancer Working Party. Zattoni F, et al. Among authors: olivier j. Eur Urol Focus. 2023 Jul;9(4):621-628. doi: 10.1016/j.euf.2023.01.016. Epub 2023 Feb 4. Eur Urol Focus. 2023. PMID: 36746729 Free article.
752 results